A Study of Dideoxycytidine in HIV-Infected Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 1988

Conditions

HIV Infections

Interventions

DRUG

Zalcitabine

Trial Locations (1)

Johns Hopkins Hosp, Baltimore

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000997 - A Study of Dideoxycytidine in HIV-Infected Patients | Biotech Hunter | Biotech Hunter